OCS News

Latest breaking news and updates for OCS stock.

Track all markets on TradingView

Oculis Reports Q2 2025 Financial Results and Provides Company Update

ZUG, Switzerland, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on breakthrough innovations to address sig...

Are there any significant pipeline milestones, regulatory approvals, or partnership announcements that could materially impact future cash flows and volatility? What guidance or outlook did the company provide for the remainder of 2025, and how might it affect the stock valuation? How did Oculis's Q2 2025 revenue and earnings compare to consensus estimates and prior quarters?
Earnings
4 days ago
Read more globenewswire

Oculis Reports Q2 2025 Financial Results and Provides Company Update

ZUG, Switzerland, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on breakthrough innovations to address signi...

How does Oculis' Q2 performance and outlook compare to its peers in the ophthalmology and neuro‑ophthalmology space? Did the company provide any guidance on upcoming product milestones or regulatory milestones that could move the stock? What were Oculis' Q2 2025 revenue and earnings versus analyst expectations?
Earnings
4 days ago
Read more globenewswire

Oculis to Participate in Upcoming H.C Wainwright 5th Annual Ophthalmology Virtual Conference

ZUG, Switzerland, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neur...

What are the possible implications for Oculis’ cash burn and financing needs if new initiatives are announced? How might the market react if Oculis provides updates on its neuro‑ophthalmic programs? Is there any expectation of a change in analyst coverage or rating upgrades/downgrades following the conference?
Conference
13 days ago
Read more globenewswire

Oculis to Participate in Upcoming H.C. Wainwright 5th Annual Ophthalmology Virtual Conference

ZUG, Switzerland, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neur...

What potential risks or downside catalysts could be highlighted during the management presentation? How might the conference influence trading volume and liquidity for OCS shares? Will the virtual conference provide insights into Oculis' long‑term growth strategy and market positioning?
Events
13 days ago
Read more globenewswire